When it comes to Valeant and Allergan, why not bet on both?
Valeant and hedge fund manager Bill Ackman continued their pursuit of botox maker Allergan this week. On Monday, Ackman’s hedge fund Pershing Square unveiled his slate of directors for Allergan’s board. And while much has been made about how the deal may play out, according to Galiant Capital’s President and CEO Ian Shaffer, both stocks might be a good buy.
Franklin Cameron, Producer, BNN
Posted on 7-11-2014 at 5:04 PM